Zobrazeno 1 - 10
of 1 177
pro vyhledávání: '"sst2"'
Autor:
Elisa Lamback, Renan Lyra Miranda, Leila Chimelli, Felipe Andreiuolo, Leandro Kasuki, Luiz Eduardo Wildemberg, Mônica R Gadelha
Publikováno v:
Endocrine Oncology, Vol 4, Iss 1, Pp 1-6 (2024)
Pituitary gigantism is a rare pediatric disorder caused by excess growth hormone (GH) secretion. In almost 50% of cases, a genetic cause can be identified, with pathogenic variants in the aryl hydrocarbon receptor-interacting protein (AIP) gene being
Externí odkaz:
https://doaj.org/article/316e8ec52eb247dea7230b033c716974
Autor:
Yuyi Chen, Jingyuan Guan, Chen Qi, Yihang Wu, Jing Wang, Xuemei Zhao, Xinqing Li, Chunhui He, Jian Zhang, Yuhui Zhang
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 2857-2868 (2024)
Abstract Aims This study aimed to investigate the association of soluble suppression of tumorigenicity‐2 (sST2) measured by point‐of‐care testing assay with clinical outcomes in patients hospitalized with heart failure after adjusting for other
Externí odkaz:
https://doaj.org/article/d53f1b96b0c44c45b7c99733086d43e4
Autor:
Tatiana P. Gizatulina, Aleksandra V. Mamarina, Leysan U. Martyanova, Denis V. Belonogov, Grigoriy V. Kolunin, Tatiana I. Petelina, Nikita E. Shirokov, Elena A. Gorbatenko
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background and objectives :The hypothesis of the study was the assumption that the serum levels of soluble ST2 (sST2) and growth differentiation factor (GDF-15) can be predictors of atrial fibrillation (AF) recurrence in long-term period aft
Externí odkaz:
https://doaj.org/article/2c3e71bf3d684639a7c16236844d046a
Publikováno v:
PeerJ, Vol 12, p e18142 (2024)
Background Hepatocellular carcinoma (HCC) is a common malignant tumor with high morbidity and mortality. Alpha-fetoprotein (AFP) is the most widely used diagnostic serum biomarker, but it still has limited accuracy in detecting HCC, suggesting the ne
Externí odkaz:
https://doaj.org/article/ddafd3168ec14c16bb395d6be8a40466
Publikováno v:
Journal of Biomedicine and Biochemistry, Vol 3, Iss 2, Pp 1-9 (2024)
Background Cardiovascular disease (CVD) is an umbrella term for a group of illnesses that have an adverse effect on the cardiovascular system. Diabetic cardiomyopathy and atherosclerotic CVD, which may cause heart failure via myocardial infarction an
Externí odkaz:
https://doaj.org/article/646d8d2e8cbe4be3b83029425bbe6781
Autor:
N. B. Kuz, T. M. Solomenchuk
Publikováno v:
Zaporožskij Medicinskij Žurnal, Vol 26, Iss 3, Pp 178-183 (2024)
Aim. To evaluate the levels of soluble growth stimulator gene 2 (sST2) protein and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with acute coronary syndrome (ACS) depending on the presence of concomitant subclinical hypothyroidism
Externí odkaz:
https://doaj.org/article/17529df7c5c44c13affd2922ad2a2039
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 7 (2024)
Aim. To study the effect of extended-release (XR) metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with heart failure with preserved ejection fraction (HFpEF), prediabetes and abdominal obesity (AO).Material
Externí odkaz:
https://doaj.org/article/7c51200a37ba47a49422ec2625583299
Publikováno v:
Open Life Sciences, Vol 19, Iss 1, Pp 171-8 (2024)
Externí odkaz:
https://doaj.org/article/71b8553dd2484999a2b7791e8eb1d3c9
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 1, Pp 31-37 (2024)
The results of a pilot study of the serum marker of cardiac damage sST2 in patients with chronic generalized sarcoidosis are presented. Correlations between the activity of sarcoidosis, sST2 levels and the risk of developing heart failure have been d
Externí odkaz:
https://doaj.org/article/c536e132b7d84f3599f0656ddd16c227
Autor:
Florian F. Hildenbrand, Barbara Illi, Stefanie von Felten, Jacqueline Bachofner, Joanna Gawinecka, Arnold von Eckardstein, Beat Müllhaupt, Joachim C. Mertens, Sena Blümel
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background & aims With the increase in patients at risk of advanced liver disease due to the obesity epidemic, there will be a need for simple screening tools for advanced liver fibrosis. Soluble suppression of tumorigenicity 2 (sST2) is a s
Externí odkaz:
https://doaj.org/article/1f4c8cc6076b4a0e814ca5c7d875fdd2